Scleroderma patients with renal disease live longer after kidney transplant, study finds
from Scleroderma News
A European Union study found that patients with end-stage renal disease (ESRD) due to scleroderma who undergo a kidney transplant have a greater chance of surviving for five years or more, compared to those who receive renal replacement therapy (RRT) only — a treatment involving dialysis, which consists of long-term blood-filtration interventions.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063